Inhibition of p38 MAPK activation attenuates esophageal mucosal damage in a chronic model of reflux esophagitis.

MLA

Zhang, L., et al. “Inhibition of P38 MAPK Activation Attenuates Esophageal Mucosal Damage in a Chronic Model of Reflux Esophagitis.” Neurogastroenterology and Motility, vol. 27, no. 11, Nov. 2015, pp. 1648–56. EBSCOhost, https://doi.org/10.1111/nmo.12664.

APA

Zhang, L., Liu, G., Han, X., Liu, J., Li, G.-X., Zou, D.-W., & Li, Z.-S. (2015). Inhibition of p38 MAPK activation attenuates esophageal mucosal damage in a chronic model of reflux esophagitis. Neurogastroenterology and Motility, 27(11), 1648–1656. https://doi.org/10.1111/nmo.12664

Chicago

Zhang, L, G Liu, X Han, J Liu, G-X Li, D-W Zou, and Z-S Li. 2015. “Inhibition of P38 MAPK Activation Attenuates Esophageal Mucosal Damage in a Chronic Model of Reflux Esophagitis.” Neurogastroenterology and Motility 27 (11): 1648–56. doi:10.1111/nmo.12664.